Welcome to our dedicated page for Panacea Life Sciences Hldgs news (Ticker: PLSH), a resource for investors and traders seeking the latest updates and insights on Panacea Life Sciences Hldgs stock.
Panacea Life Sciences Holdings, Inc. (PLSH) generates news across multiple areas of the natural health and wellness industry, reflecting its role as a holding company for plant-based ingredient and product businesses. Company announcements cover developments in nutraceuticals, cannabinoid products, functional mushrooms, kratom, kava, and other natural health offerings for humans and animals, as well as updates on research, retail expansion and distribution partnerships.
News items frequently highlight Panacea’s manufacturing and research activities at its cGMP facility in Golden, Colorado, including clinical and open-label studies involving CBD/CBG formulations and collaborations with academic institutions on mushroom analytics and dietary supplement trials. Investors and observers can find updates on how these efforts support the company’s goal of addressing unmet needs in health and wellness through plant-based ingredients.
Panacea’s news flow also includes coverage of acquisitions and agreements that extend its presence into natural health and wellness retail chains, franchise models and distribution networks. Examples include transactions involving retail locations in the Tampa, Florida area, the PÜR LIFE Medical franchise, and a Letter of Intent related to Sierra Sage Herbs and Halucenex. These stories illustrate how the company is pursuing a vertically integrated approach spanning manufacturing, branded products, clinics and retail outlets.
In addition, Panacea reports on licensing and distribution relationships, such as its agreement with Sky Wellness for CBD product marketing and development and its exclusive distribution agreement with QR Joy to distribute Fume disposable vape devices in the U.K. More recently, the launch of Benivita PLSH has introduced news related to a direct-to-consumer telemedicine and non-insurance benefits platform. Readers interested in PLSH can use this news page to follow the company’s evolving activities in natural health products, alternative therapies, retail expansion and telemedicine-based benefits.
Panacea Life Sciences Holdings (OTCID: PLSH) and Benivita Inc. launched Benivita PLSH on November 18, 2025, a direct-to-consumer membership platform for non-insurance benefits, telemedicine, and lifestyle discounts.
The platform combines PLSH operations, Benivita marketing, and an exclusive license from New Benefits (serving >25 million members). Plans start at $59.95 monthly for individuals. Financials show projected EBITDA $1.2M (2026), $5.2M (2027), $8.3M (2028) and a target of 100,000 members within 36–60 months. PLSH will own 100% of the new LLC, issue 16M restricted shares to Benivita and up to 125M performance shares.
Panacea Life Sciences (PLSH) has signed a Supply, Licensing, and Development Agreement with Sky Wellness for the marketing and sale of CBD products. Sky Wellness will provide its current inventory, and Panacea will handle marketing and sales, splitting net sales revenue 60% to Sky Wellness and 40% to Panacea. The agreement allows Panacea to use Sky Wellness' trademarks and intellectual property for new product development, including CBD and non-CBD dog chews and a male enhancement product. Panacea plans to stock these products at its retail locations in Tampa, Florida.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
FAQ
What is the current stock price of Panacea Life Sciences Hldgs (PLSH)?
What is the market cap of Panacea Life Sciences Hldgs (PLSH)?
